HT
NVO

HighTower Trust’s Novo Nordisk NVO Stock Holding History

HighTower Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$12.2M Hold
172,456
– – 1.19% 16
2022
Q4 		$11.5M Sell
172,456
-2,634
-2% -$154K 1.11% 20
2022
Q3 		$8.72M Buy
175,090
+133,976
+326% +$7.18M 0.96% 21
2022
Q2 		$732 Sell
41,114
-31,718
-44% -$1.76M 0.08% 116
2022
Q1 		$4.04M Buy
72,832
+270
+0.4% +$13.9K 0.39% 44
2021
Q4 		$4.06M Sell
72,562
-180
-0.2% -$9.75K 0.4% 47
2021
Q3 		$3.49M Buy
72,742
+2
+0% +$97 0.43% 48
2021
Q2 		$3.05M Sell
72,740
-104
-0.1% -$4.03K 0.37% 51
2021
Q1 		$2.46M Buy
72,844
+396
+0.5% +$14.1K 0.33% 57
2020
Q4 		$2.53M Sell
72,448
-410
-0.6% -$14.2K 0.36% 53
2020
Q3 		$2.53M Buy
72,858
+2,100
+3% +$70K 0.4% 50
2020
Q2 		$2.32M Buy
70,758
+124
+0.2% +$3.96K 0.35% 52
2020
Q1 		$2.13M Hold
70,634
– – 0.37% 51
2019
Q4 		$2.04M Hold
70,634
– – 0.25% 59
2019
Q3 		$1.83M Buy
70,634
+266
+0.4% +$6.73K 0.23% 60
2019
Q2 		$1.8M Buy
+70,368
New +$1.74M 0.23% 61

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HighTower Trust's NVO Position: Q1 2023 in Review

HighTower Trust held its Novo Nordisk (NVO) position steady in Q1 2023 at 172,456 shares worth $12.2M. The position accounts for 1.19% of the portfolio, ranked #16.

HighTower Trust first reported a position in NVO in Q2 2019 and has held it in 16 quarters since. 1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • HighTower Trust held 172,456 shares of Novo Nordisk worth $12.2M as of Q1 2023.
  • HighTower Trust left its Novo Nordisk share count unchanged in Q1 2023.
  • Novo Nordisk made up 1.19% of HighTower Trust's portfolio in Q1 2023, its #16 holding.
  • HighTower Trust first reported a position in Novo Nordisk in Q2 2019 and has held it in 16 quarters since.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.